Clinical and Patient Outcomes of 4 mm Ultra-Short vs. 8 mm Implants With Bone Augmentation in the Back Upper Jaw

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversitat Internacional de Catalunya

About this trial

This study aims to compare 2 different groups of patients with both a healed site in the upper posterior sector after extractions, one treated with ultra-short implants, and another with long implants with bone regeneration. The objective is to evaluate if short-implants are superior in terms of better clinical outcomes, survival rates and safety, reduced surgical time, postoperative discomfort, and complication risk compared to conventional implants and bone regeneration.

Eligibility criteria

Qualifiers

Inform consent signed.

Adult patients (≥18 years old).

No pregnant women or without the desire to stay.

Periodontal and peri-implant health in a pristine or reduced periodontium.

Disqualifiers

Patients with uncontrolled systemic diseases.

Smoker patients (≥10 cig/day).

Patients taking medications that affect bone metabolism or immunologic disorders.

Patients allergic to penicillin.

Trial design

Treatments tested in this trial

  • Ultra short implants
  • Long implants with bone augmentation

Treatment groups

35 Participants
are divided into 2 treatment groups

Locations

This trial has no locations